165 related articles for article (PubMed ID: 36411870)
1. YTHDC1 Promotes Stemness Maintenance and Malignant Progression in Head and Neck Squamous Cell Carcinoma.
Weng J; Fan H; Liu H; Tang S; Zheng Y
Stem Cells Int; 2022; 2022():7494354. PubMed ID: 36411870
[TBL] [Abstract][Full Text] [Related]
2. Identification of m6A methyltransferase-related genes predicts prognosis and immune infiltrates in head and neck squamous cell carcinoma.
Zhang Y; Li L; Ye Z; Zhang L; Yao N; Gai L
Ann Transl Med; 2021 Oct; 9(20):1554. PubMed ID: 34790760
[TBL] [Abstract][Full Text] [Related]
3. RNA N6-methyladenosine reader IGF2BP2 promotes lymphatic metastasis and epithelial-mesenchymal transition of head and neck squamous carcinoma cells via stabilizing slug mRNA in an m6A-dependent manner.
Yu D; Pan M; Li Y; Lu T; Wang Z; Liu C; Hu G
J Exp Clin Cancer Res; 2022 Jan; 41(1):6. PubMed ID: 34980207
[TBL] [Abstract][Full Text] [Related]
4. Endothelial downregulation of nuclear m6A reader YTHDC1 promotes pulmonary vascular remodeling in sugen hypoxia model of pulmonary hypertension.
Zheng H; Wu D; Chen X; He W; Hua J; Li Q; Ji Y
Heliyon; 2024 Feb; 10(3):e24963. PubMed ID: 38318069
[TBL] [Abstract][Full Text] [Related]
5. Genomic and transcriptomic alterations in m6A regulatory genes are associated with tumorigenesis and poor prognosis in head and neck squamous cell carcinoma.
Paramasivam A; George R; Priyadharsini JV
Am J Cancer Res; 2021; 11(7):3688-3697. PubMed ID: 34354868
[TBL] [Abstract][Full Text] [Related]
6. VIRMA promotes the progression of head and neck squamous cell carcinoma by regulating
Zhu C; Cheng Y; Yu Y; Zhang Y; Ren G
Biomol Biomed; 2024 Apr; ():. PubMed ID: 38577917
[TBL] [Abstract][Full Text] [Related]
7. Long noncoding RNA lnc-H2AFV-1 promotes cell growth by regulating aberrant m6A RNA modification in head and neck squamous cell carcinoma.
Chen X; Liu Y; Sun D; Sun R; Wang X; Li M; Song N; Ying J; Guo T; Jiang Y
Cancer Sci; 2022 Jun; 113(6):2071-2084. PubMed ID: 35403343
[TBL] [Abstract][Full Text] [Related]
8. METTL3 modulates m6A modification of CDC25B and promotes head and neck squamous cell carcinoma malignant progression.
Guo YQ; Wang Q; Wang JG; Gu YJ; Song PP; Wang SY; Qian XY; Gao X
Exp Hematol Oncol; 2022 Mar; 11(1):14. PubMed ID: 35287752
[TBL] [Abstract][Full Text] [Related]
9. HMGA2-Snai2 axis regulates tumorigenicity and stemness of head and neck squamous cell carcinoma.
Li Z; Wu X; Li J; Yu S; Ke X; Yan T; Zhu Y; Cheng J; Yang J
Exp Cell Res; 2022 Sep; 418(1):113271. PubMed ID: 35764101
[TBL] [Abstract][Full Text] [Related]
10. Clinical Significance of an m6A Reader Gene,
Deng X; Jiang Q; Liu Z; Chen W
Front Mol Biosci; 2020; 7():68. PubMed ID: 32391379
[TBL] [Abstract][Full Text] [Related]
11. PLEK2 promotes cancer stemness and tumorigenesis of head and neck squamous cell carcinoma via the c-Myc-mediated positive feedback loop.
Zhao X; Shu D; Sun W; Si S; Ran W; Guo B; Cui L
Cancer Commun (Lond); 2022 Oct; 42(10):987-1007. PubMed ID: 36002342
[TBL] [Abstract][Full Text] [Related]
12. SOX2 regulates self-renewal and tumorigenicity of stem-like cells of head and neck squamous cell carcinoma.
Lee SH; Oh SY; Do SI; Lee HJ; Kang HJ; Rho YS; Bae WJ; Lim YC
Br J Cancer; 2014 Nov; 111(11):2122-30. PubMed ID: 25321191
[TBL] [Abstract][Full Text] [Related]
13. The RNA m6A-Binding Protein YTHDC1 Is Downregulated and Associated With M2 Macrophage Infiltration in Muscle-Invasive Bladder Cancer.
Zhao L; Han D; Zhu J; Bi D; Ding T; Zhu X; Huang D; Zhang Y; Lu L; Wu W; Gao Y; Liu H; Huang Q; Wei Q; Yao X
Clin Med Insights Oncol; 2023; 17():11795549231203150. PubMed ID: 37901254
[TBL] [Abstract][Full Text] [Related]
14. Low expression of m6A reader YTHDC1 promotes progression of ovarian cancer via PIK3R1/STAT3/GANAB axis.
Wang X; Chen Q; Bing Z; Zhou S; Xu Z; Hou Y; Zhao Y; Zhao S; Wang T
Int J Biol Sci; 2023; 19(14):4672-4688. PubMed ID: 37781028
[No Abstract] [Full Text] [Related]
15. MicroRNA-34a regulates epithelial-mesenchymal transition and cancer stem cell phenotype of head and neck squamous cell carcinoma in vitro.
Sun Z; Hu W; Xu J; Kaufmann AM; Albers AE
Int J Oncol; 2015 Oct; 47(4):1339-50. PubMed ID: 26323460
[TBL] [Abstract][Full Text] [Related]
16. Novel prognostic matrisome-related gene signature of head and neck squamous cell carcinoma.
Huang C; Liang Y; Dong Y; Huang L; Li A; Du R; Huang H
Front Cell Dev Biol; 2022; 10():884590. PubMed ID: 36081907
[No Abstract] [Full Text] [Related]
17. The RNA N6-Methyladenosine Demethylase FTO Promotes Head and Neck Squamous Cell Carcinoma Proliferation and Migration by Increasing CTNNB1.
Zhang Y; Chen L; Wu X; Sun Z; Wang F; Wang B; Dong P
Int J Gen Med; 2021; 14():8785-8795. PubMed ID: 34853532
[TBL] [Abstract][Full Text] [Related]
18. UBE2C promotes the progression of head and neck squamous cell carcinoma.
Jin Z; Zhao X; Cui L; Xu X; Zhao Y; Younai F; Messadi D; Hu S
Biochem Biophys Res Commun; 2020 Mar; 523(2):389-397. PubMed ID: 31870550
[TBL] [Abstract][Full Text] [Related]
19. Analysis of Genetic Alteration Signatures and Prognostic Values of m6A Regulatory Genes in Head and Neck Squamous Cell Carcinoma.
Zhou X; Han J; Zhen X; Liu Y; Cui Z; Yue Z; Ding L; Xu S
Front Oncol; 2020; 10():718. PubMed ID: 32547941
[TBL] [Abstract][Full Text] [Related]
20. Inhibitor of DNA binding 2 is a novel therapeutic target for stemness of head and neck squamous cell carcinoma.
Bae WJ; Koo BS; Lee SH; Kim JM; Rho YS; Lim JY; Moon JH; Cho JH; Lim YC
Br J Cancer; 2017 Dec; 117(12):1810-1818. PubMed ID: 29096401
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]